HMMR and prostate cancer: To get an idea of the extent of RHAMM expression in prostate cancer patient tumors, we performed IHC staining of another TMA that contained triplicate tissue cores from 14 benign prostate tissue samples, 14 prostate cancer, 11 CRPC, and nine NEPC tumors.